Transformative Cardiac Solutions From AliveCor
Source: AliveCor BioPharma
Learn how AliveCor is transforming cardiac solutions with its ECG devices. While traditional ECGs require on-site visits, delaying data and increasing drop-out risk, AliveCor''s FDA-Cleared ECG devices can be used on-site as well as in decentralized and fully remote trials. From 6-lead to 12-lead, these devices detect the most common arrhythmias, QT prolongation, and more. In this video, you will learn everything you need to know about these AI-drive, real-time, compliant ECG insights and how the solutions are helping trials globally.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader